Let’s meet at CPHI Milan 2026

Connecting research, development, manufacturing, and supply to cut through outsourcing complexity and streamline the drug development journey.

October 6–8, 2026

In-person

Fiera Milano, Italy

Booth: 6A2

Event website

Drug development no longer happens in isolated stages

As programs become increasingly interconnected, decisions made in one part of the process often affect outcomes in another.

When biotech and pharma companies work with multiple third-party partners, challenges can arise:

Repeated handoffs between vendors, increasing complexity as knowledge and processes are transferred
Limited visibility across the development lifecycle, resulting in disconnected data and decision-making
Siloed teams and unclear ownership, creating communication gaps and reducing operational efficiency

As a result, critical activities are executed independently, creating a fragmented approach that lacks strategic alignment.

We offer a better way.

Why Thermo Fisher Scientific?

Thermo Fisher Scientific offers a coordinated suite of solutions that integrates CDMO and CRO capabilities across the drug development ecosystem, with services purpose-built to support programs across therapeutic areas and drug modalities.

As your end-to-end partner, we're always looking ahead. During formulation development, we're already considering later-stage manufacturing requirements. As clinical trials progress, we're helping lay the groundwork for global supply chain readiness.

This forward-looking approach helps reduce friction, maintain continuity, and improve decision-making from early development through commercial manufacturing and beyond—ultimately supporting your goal of getting treatments to patients faster.

About CPHI Milan 2026:

As the premier event connecting global industry experts, CPHI unites the world of pharma. From experiences that inspire innovation and drive change to in-person opportunities that foster meaningful relationships year-round, CPHI is your one-stop destination for joining a community dedicated to advancing health.

CPHI Milan 2026 will bring together top suppliers, innovators, and pharmaceutical professionals from across the biotechnology and pharmaceutical supply chain. Many of the industry's leading companies will be in attendance, including Thermo Fisher Scientific. Our team of experts looks forward to seeing you there.

Schedule a 1:1 at CPHI Milan 2026

Let's begin our journey together by meeting at CPHI Milan 2026 and discussing the specific needs of your drug development program.

Find your missing element with Thermo Fisher Scientific

Element

Trust is the foundation of a successful partnership. It allows partners to work as one team, guided by a shared vision, with the confidence that each partner reliably do what they say they will do.

Transparent and open communication is a key element to successful project management. It requires sharing relevant information, feedback, and expectations and it encourages dialogue to address concerns and issues promptly.

Element

An effective partnership is built on mutual respect, open communication, trust, collaboration, and shared objectives, instilling confidence in customers that they will be fully supported along the development journey.

Element

Enabled through tools, technologies, and industry and scientific expertise, foresight enables teams to anticipate and mitigate challenges before they arise.

Element

Navigating the complexities of drug development and manufacturing requires passion, persistence, and unwavering dedication to achieving the shared vision of transforming patients’ lives.

Element

Every project has unique requirements, objectives, and challenges. Close and continuous collaboration is vital for understanding these distinct considerations and tailoring solutions to meet them.

Element

Real-world experience borne from decades of partnering in all aspects of drug development adds critical value to every project above and beyond the advances in sciences and technology that have transformed the industry.

Element

Scientists and subject matter experts with deep understanding of the evolving pharmaceutical landscape provide the skills and perspective to set and keep projects on the path to success.

Element

Scientific, technical, and operational knowledge acquired through deep and wide industry experience is an inimitable competitive differentiator in today’s rapidly evolving industry landscape.

Element

Keeping pace with the rapidly changing pharmaceutical industry requires unprecedented operational agility and flexibility to consistently deliver high-quality, customized solutions.

Insights and resources

White paper

Transforming CDMO partnerships through a holistic understanding of quality

Get an in-depth look into key indicators of CDMO quality, with tools and best practices to drive continuous improvement, strengthen collaboration, and ultimately cultivate trust.

Download white paper

Blog post

Enter the CRDMO: Reshaping drug development through CRO/CDMO integration

CRDMOs, or integrated contract research, development, and manufacturing organizations, are a trend to watch. Discover five benefits of partnering with one.

Read blog

Blog post

The 5 drug development phases

To be deemed a “success,” a new drug must make it through five specific phases: 1) discovery and development, 2) preclinical research, 3) clinical research, 4) FDA review, and 5) safety monitoring.

Read blog

Blog post

CDMO 2.0: Three pharma industry trends for 2024 and beyond

Discover three major trends expected in the pharma industry, including turning to flexible manufacturing, embracing digital enablement, and the need for CDMOs deliver transformational value.

Read blog

The quality lever: Shaping success in CDMO partnerships

Compromising on quality can lead to detrimental impacts on both speed and cost, ultimately affecting the successful development and marketing of new therapies.

Read blog

Blog post

What is a CDMO and what to look for in a partner

Learn how CDMOs (contract development and manufacturing organizations) work with pharma companies, and the top considerations companies have when choosing a CDMO partner.

Read blog

Blog post

CROs vs CMOs, and CDMOs: What’s the difference between the three?

CROs, CMOs, and CDMOs all help biotechnology and pharmaceutical companies with drug development and manufacturing, but what’s the difference between the three?

Read blog

Webinar

Optimizing the cell therapy patient journey through integrated CRO CDMO partnership

Watch this on-demand webinar for insights on how working with a single integrated CRO/CDMO partner can help ease industry challenges and provide an accelerated path from development to manufacturing, as well as the benefits that come from unified teams and infrastructure.

Watch webinar

Infographic

CDMO checklist to launch your molecule globally

Preparing to take your drug into the global market? You’ll need to make sure your CDMO has what it takes to successfully navigate the global regulatory space with speed, security, and supply safeguards. Use this quick list as a reference when evaluating your options.

Download infographic

Blog post

Enabling a digital culture through integrated business processes

In contrast to a physical work environment, where stability and experience are key, a digital business environment focuses on innovation and connectivity. Learn more.

Read blog

Whitepaper

The changing landscape of oncology drug development: Bringing novel lifesaving therapies to patients

Oncology is the fastest-growing, most active sector of drug development. Matching drug products to clinical and commercial needs requires scientific and technological innovation.

Download whitepaper

eBook

Protecting tomorrow: Supporting pharmaceutical and biotech industries to build a sustainable future

Learn how Thermo Fisher is meeting its environmental sustainability goals, and how we work in partnership with the pharma and biotech communities on shared environmental sustainability goals.

Download eBook

Infographic

Preparing biologics for commercialization: Understanding Strategies to Reduce Risk and Optimize Outcomes in Drug Development

Within the drug development process, there are several steps that occur between the laboratory and final manufacture of the drug product. Different players step in during each point, so keeping a program with many moving parts on track requires planning and time-tested execution approaches.

Download infographic

White paper

Advancing drug development using in silico modeling

This report provides a framework for that understanding by outlining some of the processes that stand to gain the most from computational modeling and identifying the in silico capabilities that can be used to accelerate and de-risk each phase of development.

Download white paper

Discover a different kind of CDMO at CPHI

Stay connected to new discoveries, innovations, and expert scientific opinions.

View insights and resources

Ready to discuss your project?

Find your missing element with Thermo Fisher Scientific